CPhI Online

- Market News

Ex-Legacy Pharmaceuticals machinery and equipment up for sale, says Hilco Industrial

Gareth Carpenter — 6 May 2021

Industrial assets purchaser is offering high-capacity production line equipment formerly owned by bankrupt CMO

Industrial assets purchaser Hilco Industrial Acquisitions says it is trying to bring back to the pharmaceutical market all machinery and equipment it purchased from bankrupt CMO Legacy Pharmaceuticals in a liquidation sale in March.

Switzerland-based Legacy, which specialised in fill/finish of sterile and semi-solid drug products, filed for bankruptcy in December 2020, resulting in over 200 job losses. At the time the company said the move had been driven by non-payment of important customers.

However, in October 2020, Legacy had been forced to stop manufacturing sterile drugs by Swissmedic after its facility failed an inspection by the Swiss drug regulator.

Darko Pepovski, Vice President Sales & Marketing of Hilco in the Netherlands, said his challenge is to bring the high-capacity production lines back to the market.

“To do so, we have started a worldwide marketing and sales campaign, making potential buyers in the pharmaceutical and associated industries aware of the opportunity to acquire the excellently maintained, late-model equipment needed, to increase their production capacities, especially in these days of high demand for injectables due to COVID,” he said.

To view the online auction for the ex-Legacy equipment, click here.

Related Content